Author

Natalie Telis

Helix (United States)ORCID 0000-0002-4813-6893Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Natalie Telis2 papers

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 5

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 5 Approach:statistical model· 4 Research Focus:GWAS / association mapping· 2 Research Focus:variant effect prediction· 2 Assay:whole-exome sequencing· 2 Assay:GWAS summary statistics· 1 Research Focus:variant calling· 1

Frequent Co-Authors

Alexandre BolzeiD· 5 shared Elizabeth T. CirulliiD· 5 shared Joseph J. GrzymskiiD· 5 shared Kelly M. Schiabor BarrettiD· 5 shared Nicole L. WashingtoniD· 5 shared Lisa M. McEweniD· 4 shared Catherine A. HajekiD· 3 shared Daniel Philip JudgeiD· 3 shared

Activity by Year

2023-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

5 shared papersGenetic & Genomic Medicine

Alexandre BolzeORCID

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Genetic & Genomic MedicineCirculation Genomic and Precision MedicinePeer-reviewedNov 5, 2025

Population genomic screening leads to improved lipid management in patients with familial hypercholesterolemia

Matthew E. Levy, Kelly M. Schiabor Barrett, Megan N. Betts…·Catherine A. Hajek

Population genomic screening identified familial hypercholesterolemia patients, leading to improved lipid-lowering therapies and LDL-C reductions.

1 citation

humanwhole-exome sequencing

Genetic & Genomic MedicinemedRxivPreprintNov 1, 2024

A novel method for predicting Lp(a) levels from routine outpatient genomic testing identifies those at risk of cardiovascular disease across a diverse cohort

Natalie Telis, Hang Dai, Ashley Arana Waring…·Kelly M. Schiabor Barrett

This paper develops a method to predict Lp(a) levels from genomic data, combining SNV risk scores and KIV-2 repeat counts, and shows it improves risk prediction for cardiovascular disease in diverse populations.

DOI 10.1101/2024.11.01.24316526

humanwhole-exome sequencing

Genetic & Genomic MedicineGenetics in Medicine OpenPeer-reviewedJan 1, 2024

Combining rare and common genetic variants improves population risk stratification for breast cancer

Alexandre Bolze, Daniel Kiser, Kelly M. Schiabor Barrett…·Joseph J. Grzymski

This study evaluates genetic screening approaches for breast cancer risk, finding that combining rare and common variants improves risk stratification.

11 citations

humanGWAS summary statistics

Genetic & Genomic MedicinemedRxivPreprintDec 19, 2023

Patients with Type 2 Diabetes and a GCK variant are still at risk for T2D-related secondary complications

Kelly M. Schiabor Barrett, Natalie Telis, Lisa M. McEwen…·Elizabeth T. Cirulli

The paper identifies GCK variant carriers at increased risk for T2D and its complications, despite their glucose elevations not meeting standard T2D criteria.

DOI 10.1101/2023.12.19.23300223

humanstatistical model

Genetic & Genomic MedicinemedRxivPreprintOct 30, 2023

Hypertension increases PPV for polycystic kidney disease in PKD1 and PKD2 variant carriers

Natalie Telis, Lisa M. McEwen, Alexandre Bolze…·Elizabeth T. Cirulli

The paper investigates the impact of hypertension on the positive predictive value (PPV) for polycystic kidney disease in carriers of PKD1 and PKD2 variants.

DOI 10.1101/2023.10.30.23297693